BAILARD, INC. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2022$1,812,000
-65.2%
35,867
-56.0%
0.07%
-59.4%
Q1 2022$5,203,000
-50.4%
81,444
-16.8%
0.18%
-47.6%
Q4 2021$10,488,000
+3.1%
97,916
-1.0%
0.33%
-4.0%
Q3 2021$10,172,000
+36.6%
98,939
+16.9%
0.35%
+35.4%
Q2 2021$7,445,000
+993.2%
84,645
+1109.2%
0.26%
+928.0%
Q1 2021$681,0007,0000.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2022
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders